OrthoPediatrics-Aktie 52-Wochen-Tief $24.01 Von Investing.com

OrthoPediatrics Corp. (KIDS) Aktie von OrthoPediatrics Corp. (KIDS), the 52-Wochen-Tief, a medical device specialized in pediatrics, costs $24.01. Shortly thereafter, we achieved a more widespread reversal, resulting in an increase of -6.87%. OrthoPediatrics Courses, versatile wirtschaftliche Faktoren Investoren dazu veranlasst haben, die Wachstumsaussichten von Aktien aus dem Gesundheitssektor new zu bewerten. The real Tiefstands ensured Unternehmen beyond a Mission, das Leben von Kindern mit ortopedishchen Erkrankungen zu und Stakeholder in Leistung des Unternehmens auf der Suche nach Anzeichen einer Erholung.

OrthoPediatrics Corporation’s recent significant figure was a record $54.6 Million in Q1 2024, accounting for a 37% share of annual revenue. This solid Wachstum has lasted a very long time in terms of Marking, Production and Solid Performance in Schlüsselsegmente Encountered with Trauma, Deformation and Risks. Unternehmen, which had a significant estimate for Gesamtjahr of $202 to $204 Million, had a Wachstum of 36% to 37%.

OrthoPediatrics was Vorjahr’s largest revenue earner, 50%, over a period of 33,000 Kinders. Segment Trauma and Deformity totaled 31% at $37.6 Million, while the Skoliose Segment totaled 52% at $15.6 Million. Das Unternehmen baut auch sein chirurgisches Geschäft mit speciellen aus, mit dem Ziel, den Marktanteil zu erhöhen und jährlich new Product.

Trotz delivered a return of $45.6M, a cost of operations of 29% and a Bruttomarge of 73%. OrtoPediatrics stated that Bezug is optimistic in Wachstumsstrategie and Produktpipeline and strebt an and Cash Flow is positive from 2026.

InvestingPro Insights

OrthoPediatrics Corp. (KIDS) has managed to navigate all types of markets, with a wider range of performance. Laut InvestingPro-Data also caused an Einbruch to operate openly, with an increase of -16.2%. It dies with Erwähnung in Artikel, which means that 52-Wochen-Tief has a correct hat.

The number of young people in childhood is a positive indicator for OrthoPediatrics. An Investment Pro-Tip hervore, a Gewinnprognosen analysis for a good performance in the next period, had good potential for subsequent performance. Darüber achieved a very high figure in South America with an Anstieg of 33.47% and a Wachstum of 36.53% in the fourth quarter.

Earn Profitability in One Theme. This Unternehmen, together with an operational Gewinnmarge of -15.3%, allows Monaten to make no profit. With wider use of InvestingPro-Tipp it became clear that the analysis provided no benefit and was not something from which to make a profit.

Für Investoren, die eine umfassendere Analysis such a, bietet InvestmentPro 7 Useful Tips for OrthoPediatrics, Verständnis on Finance and Brand Status of Unternehmens Ermöglichen.

Diese Übersetzung wurde mithilfe künstlicher Intelligenz erstellt. Learn more about the required information.